Bio-resilience as Collective Security Infrastructure
The EU–NATO Medical Countermeasures Alliance and the European Industrial Ecosystem for MCM, CBRN Readiness, and Strategic Stockpiling
23 pages · PDF · 06 March 2026 · Licensed single-user copy, watermarked to the buyer
€499 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
The COVID-19 pandemic and the subsequent reassessment of biological threats in the context of geopolitical competition have accelerated a structural shift in how European institutions conceptualise health security.
Medical countermeasures—vaccines, therapeutics, diagnostics, and associated detection and protection capabilities—are increasingly treated not solely as instruments of public health policy but as components of collective security infrastructure.
Key questions this report answers
- How are medical countermeasures such as vaccines, therapeutics, diagnostics, and detection reconceived as collective security infrastructure?
- How do institutions like HERA, the EU Stockpiling Strategy, rescEU, and the Medical Countermeasures Alliance structure Europe's bio-resilience?
- What industrial ecosystem, stockpiling, procurement, and financing arrangements are needed to build and sustain this capacity?
- What governance, standards, and security-of-supply risks could break the system, and what are the implications for EU-NATO readiness?
Inside this report
- Strategic Context: Bio-resilience as Collective Security Infrastructure
- Institutional Architecture: HERA, EU Stockpiling Strategy, and rescEU as Capabil
- The Four Capability Blocks of the Medical Countermeasures Alliance
- Industrial Ecosystem Mapping: What Must Exist to Make the System Real
- Stockpiling as Infrastructure: From National Inventories to Coordinated EU Reser
- CBRN Medical Countermeasures and Civil–Military Interoperability
- De-risking, Procurement, and Financing: How Capacity Is Created and Sustained
- Governance, Standards, and Security-of-Supply: What Can Break the System
- Implications for EU–NATO Readiness and European Industrial Policy
- Conclusion: Bio-resilience as a Permanent Defence-Adjacent Industrial Domain
Who it's for
Strategy, corporate-development and investment teams that need an ecosystem-level view — budgets, industrial capacity and technology landscapes — before committing capital or capacity.
Methodology & sources
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; the report reflects them as of its publication date (06 March 2026).
Format & delivery
23-page PDF, watermarked to you (name, e-mail, order number on every page). Delivered immediately after checkout on the confirmation page and by e-mail; the personal link is valid for 72 hours and up to 5 downloads (re-issued on request). Guest checkout — no account required. Single-user licence: see the Terms of Sale.
The full analysis, not the summary
The public briefing linked above tells you what this report found; the report itself shows the full evidence and reasoning behind it, section by section. It is the complete, dated document from the DFM research desk — sources cited, delivered as a licensed PDF you can keep and cite in your own work.
Related on DFM
More Strategic reports · Military Medical Tech · Bio Detection & CBRN · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →